GLYCEMIC IMPROVEMENT IN 1,311 PATIENTS WITH TYPE 1 DIABETES (T1D) USING THE OMNIPOD DASH® INSULIN MANAGEMENT SYSTEM OVER FIRST 90 DAYS OF USE

被引：0
|
作者：
Aleppo, G. [1 ]
Desalvo, D. [2 ]
Lauand, F. [3 ]
Huyett, L. [4 ]
Jantz, J. [5 ]
Chang, A. [5 ]
Vienneau, T. [6 ]
Ly, T. [7 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Texas Childrens Hosp, Pediat Diabet & Endocrinol, Houston, TX 77030 USA
[3] Insulet Int, Med Affairs, Paris, France
[4] Insulet Corp, Med Affairs, San Diego, CA USA
[5] Insulet Corp, Data Analyt, Acton, MA USA
[6] Insulet Corp, Med Affairs, Acton, MA USA
[7] Insulet Corp, Clin Affairs, Acton, MA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O081 / #34
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [31] Dietary behaviors predict glycemic control in youth with type 1 diabetes (T1D)
    Mehta, Sanfeev
    Volkening, Lisa
    Anderson, Barbara
    Nansel, Tonja
    Weissberg-Benchell, Jill
    Wysocki, Tim
    Laffel, Lori
    DIABETES, 2007, 56 : A77 - A77
  • [32] Effect of the Omnipod® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII
    Mehta, Sanjeev N.
    Kruger, Davida F.
    Bode, Bruce W.
    Layne, Jennifer E.
    Dumais, Bonnie
    Gallagher, Jack R.
    Ly, Trang T.
    DIABETES, 2019, 68
  • [33] FAMILY CHAOS AND YOUTH TYPE 1 DIABETES (T1D) MANAGEMENT
    Miller, Alison L.
    Bauer, Katherine W.
    Hilliard, Marissa
    Albright, Dana
    Lee, Joyce
    Sturza, Julie
    Riley, Hurley
    Fredericks, Emily
    ANNALS OF BEHAVIORAL MEDICINE, 2024, 58 : S385 - S385
  • [34] Substance Use in Adults with Type 1 Diabetes in the T1D Exchange
    Petry, Nancy
    Foster, Nicole C.
    Cengiz, Eda
    Tamborlane, William V.
    Wagner, Julie
    Polsky, Sarit
    DIABETES, 2018, 67
  • [35] Substance Use in Adults With Type 1 Diabetes in the T1D Exchange
    Petry, Nancy M.
    Foster, Nicole C.
    Cengiz, Eda
    Tamborlane, William V.
    Wagner, Julie
    Polsky, Sarit
    DIABETES EDUCATOR, 2018, 44 (06): : 510 - 518
  • [36] GLYCEMIC OUTCOMES OF USE OF CLC VS PLGS IN TYPE 1 DIABETES (T1D): A RANDOMIZED, CONTROLLED TRIAL
    Brown, S.
    Raghinaru, D.
    Buckingham, B.
    Kudva, Y.
    Laffel, L.
    Levy, C.
    Pinsker, J.
    Wadwa, R. P.
    Lum, J.
    Beck, R.
    Kovatchev, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A34 - A34
  • [37] Pancreas Volume Declines over the First Year after Diagnosis with Type 1 Diabetes (T1D)
    Virostko, Jack
    Hilmes, Melissa A.
    Williams, Jonathan M.
    Wright, Jordan
    Du, Liping
    Kang, Hakmook
    Russell, William E.
    Moore, Daniel J.
    Powers, Alvin C.
    DIABETES, 2018, 67
  • [38] Drivers of treatment preference for the Lilly/Alkermes inhaled insulin system in patients (Pts) with type 1 diabetes (T1D)
    Hayes, RP
    Muchmore, DB
    Silverman, B
    DIABETES, 2005, 54 : A495 - A495
  • [39] Patient reported outcomes (PROs) using the Lilly/Alkermes inhaled insulin system versus injectable insulin in patients with type 1 diabetes (T1D)
    Hayes, RP
    Muchmore, DB
    Stump, TE
    Silverman, B
    DIABETES, 2005, 54 : A495 - A495
  • [40] Weight Status of Youth with Type 1 Diabetes (T1D) Over Time: Impact of Childhood Weight and Glycemic Control
    Baskaran, Charu
    Dougher, Carly
    Telo, Gabriela H.
    Katz, Michelle L.
    Hathway, Joanne
    Laffel, Lori M.
    DIABETES, 2014, 63 : A43 - A43
12345